GlassScriptPhysician profile
Amanda K Lamb
NPI 1427590637
$2,835.32
in general payments reported to CMS, 2019-2025
15 companies · $2,015 in 2025
The $2,015 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $472 · 2022: $96.08 · 2023: $169 · 2024: $83.71 · 2025: $2,015.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,475 · Food and Beverage: $745 · Education: $47.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,475.48 |
| Food and Beverage | $745.16 |
| Education | $47.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $2,141.07 | 2021-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Biohaven Pharmaceuticals, INC. | $215.88 | 2021 | |
| Ani Pharmaceuticals, INC. | $121.61 | 2023 | Purified Cortrophin Gel |
| Neurocrine Biosciences, INC. | $93.95 | 2022-2023 | Ingrezza |
| Abbvie INC. | $40.13 | 2021-2022 | |
| Biogen, INC. | $38.50 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $29.55 | 2021 | |
| Lilly USA, LLC | $29.17 | 2021 | |
| Amgen INC. | $23.50 | 2021 | |
| Lundbeck LLC | $20.40 | 2021 | |
| Vanda Pharmaceuticals INC. | $20.32 | 2021 | |
| Dexcom, INC. | $18.25 | 2025 | Dexcom G6 Transmitter |
| Collegium Pharmaceutical, INC. | $16.02 | 2025 | Jornay Pm |
| Currax Pharmaceuticals LLC | $14.27 | 2021 | |
| Eisai INC. | $12.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Lamb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.